Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.74 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.55 |
| ▸ | BLM | P54132 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | NQO2 | P16083 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27084687 | 0.92 | MTNR1A (0.73) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL27085201 | 0.90 | MTNR1A (0.73) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL29112615 | 0.89 | MTNR1A (0.80) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL27085263 | 0.89 | MTNR1A (0.71) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL27085140 | 0.88 | MTNR1A (0.74) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL29112595 | 0.87 | MTNR1A (0.69) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL27085153 | 0.87 | MTNR1A (0.69) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL25236273 | 0.85 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL14961131 | 0.84 | MTNR1A (0.74) | MTNR1AMTNR1BCYP1A2BLMMEN1 | |
| SCHEMBL31024311 | 0.83 | HTR2A (0.64) | MTNR1AMTNR1BCYP1A2BLMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043382-A1 | MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES | COMPASS PATHFINDER LIMITED (GB) | 2024-02-08 | — | — | US | disclosed |
| CN-117120415-A | Modified indole alkaloids for therapeutic use | 指南针探路者有限公司 | 2023-11-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043382-A1 | MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES | INMT, AANAT, HNMT | MTNR1A 40/4885MTNR1B 89/4885CYP1A2 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.